Cargando…
Low-dose cyclosporine in treatment of membranous nephropathy with nephrotic syndrome: effectiveness and renal safety
Background: To observe effectiveness and renal safety of long-term low-dose cyclosporine in idiopathic membranous nephropathy (IMN). Methods: Sixty-eight patients were enrolled in this prospective cohort study. Renal endpoint was defined as a decrease in eGFR ≥50% from baseline and a development of...
Autores principales: | Yu, Xiaojuan, Ruan, Lin, Qu, Zhen, Cui, Zhao, Zhang, Yimiao, Wang, Xin, Meng, Liqiang, Liu, Xiaojing, Wang, Fang, Zhang, Ying, Liu, Gang, Yang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446165/ https://www.ncbi.nlm.nih.gov/pubmed/28882100 http://dx.doi.org/10.1080/0886022X.2017.1373130 |
Ejemplares similares
-
Cyclosporine A for the treatment of refractory nephrotic syndrome with renal dysfunction
por: GAO, XIANG, et al.
Publicado: (2014) -
Significance of combined cyclosporine−prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial
por: Saito, Takao, et al.
Publicado: (2013) -
Breastfeeding by a mother taking cyclosporine for nephrotic syndrome
por: Li, Ruizhe, et al.
Publicado: (2022) -
Herbal Medicine “Shulifenxiao” Formula for Nephrotic Syndrome of Refractory Idiopathic Membranous Nephropathy
por: Cui, Hailan, et al.
Publicado: (2021) -
Nomogram to predict the progression of patients with primary membranous nephropathy and nephrotic syndrome
por: Liu, Lili, et al.
Publicado: (2021)